 | | COMPOUND: C01501 | |
| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C153H225N43O49S
|
|---|
| Exact mass |
3480.6157
|
|---|
| Mol weight |
3482.7473
|
|---|
| Sequence |
His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser
Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr |
|---|
| Organism |
|
|---|
| Type |
Peptide |
|---|
| Remark |
|
|---|
| Comment |
Glucagon is a single-chain polypeptide that contains 29 amino acid residues.
|
|---|
| Brite |
Compounds with biological roles [BR:br08001]
Hormones and transmitters
Peptide hormones
Glucagon
C01501 Glucagon
Bioactive peptides [BR:br08005]
Pancreatic peptides
Glucagon
C01501 Glucagon
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H04 PANCREATIC HORMONES
H04A GLYCOGENOLYTIC HORMONES
H04AA Glycogenolytic hormones
H04AA01 Glucagon
D00116 Glucagon (genetical recombination) (JP18) <JP/US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Glycemic Agents
Glucagon
D00116 Glucagon (genetical recombination) (JP18)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D00116 Glucagon (genetical recombination) (JP18); Glucagon (JAN/USP/INN)
7 Agents not mainly for therapeutic purpose
72 Intracorporeal diagnostic agents
722 Various function testing reagents
7229 Others
D00116 Glucagon (genetical recombination) (JP18); Glucagon (JAN/USP/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GCGR
D00116 Glucagon (genetical recombination) (JP18) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00116 Glucagon (genetical recombination)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00116
|
|---|
| Other DBs |
|
|---|
|
» Japanese version
|
|